Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: weight

Considerations for Lung Transplants in Patients with SARD-ILD

Ruth Jessen Hickman, MD  |  December 2, 2024

At this ACR Convergence 2024 session, Sonye Danoff, MD, PhD, discussed many factors that need to be considered before referring patients with SARD-ILD for lung transplantation.

Filed under:ACR ConvergenceConditionsMeeting ReportsOther Rheumatic Conditions Tagged with:ACR Convergence 2024ILDinterstitial lung disease (ILD)lung transplantlungsorgan transplantSARD-ILDsystemic autoimmune rheumatic disease-related interstitial lung disease

The 2024 ARP President’s & Merit Awards

Patrice Fusillo  |  November 26, 2024

ARP members honored for significant contributions to rheumatology research, education and patient care.

Filed under:ACR ConvergenceAwardsCareerMeeting Reports Tagged with:ACR Convergence 2024Association of Rheumatology Professionals (ARP)Awards

Better Education on Gout

Mary Beth Nierengarten  |  November 22, 2024

Experts addressed how education and follow-up for patients with gout can improve disease management and highlighted the need for a better construction of gout remission.

Filed under:ACR ConvergenceConditionsGout and Crystalline ArthritisMeeting Reports Tagged with:ACR Convergence 2024ACR Convergence 2024 goutadherenceFollow-UpGoutpatient educationRemissionserum urate levels

Risky Business: Understanding What It Means to Be at Risk for RA

Jason Liebowitz, MD, FACR  |  November 20, 2024

The goal is to identify people at risk for RA &, perhaps, prevent its onset.

Filed under:ACR ConvergenceAmerican College of RheumatologyConditionsRheumatoid Arthritis Tagged with:ACR Convergence 2024ACR Convergence 2024 RA

It’s Not Just Joint Pain

Mary Beth Nierengarten  |  November 19, 2024

Experts offered perspectives on how symptoms of rheumatic disease, such as fatigue, affect the physical, cognitive and emotional health of patients and offered solutions.

Filed under:ACR ConvergenceConditionsMeeting ReportsOther Rheumatic Conditions Tagged with:ACR Convergence 2024Exercisefatiguehealthy eatingpatient carequality of life

ACR On Air: Occupational Therapy Hones in on Making Daily Activities Easier

Vanessa Caceres  |  November 13, 2024

Occupational therapist Cheryl Crow, who lives with rheumatoid arthritis, shares the ins and outs of what OT is and how it can help those with rheumatic conditions.

Filed under:ConditionsRheumatoid Arthritis Tagged with:ACR on AirACR on Air podcastoccupational therapistsOccupational Therapypatient care

Unless Congress Acts, Medicare Reimbursement Will Remain Flat or Drop in 2025

From the College  |  November 12, 2024

The 2025 Medicare Physician Fee Schedule final rule, released Nov. 1, includes a conversion factor of $32.3465, a 2.83% drop from 2024. In response to advocacy efforts from the ACR and other medical societies, Congress recently introduced the Medicare Patient Access and Practice Stabilization Act of 2024, which would eliminate the 2.83% payment cut and provide an inflationary update for 2025 equal to 50% of the Medicare Economic Index.

Filed under:Billing/CodingLegislation & Advocacy Tagged with:ACR advocacyMedicare Physician Fee Schedule (MPFS)Medicare Reimbursement

AC&R Study Summary: Standardizing Treatment for Moderately Severe JDM

By Matthew A. Sherman, MD, MHSc, & Stacey E. Tarvin, MD, MS  |  November 10, 2024

Why was this study done? Juvenile dermatomyositis (JDM) is the most common type of idiopathic inflammatory myopathy in childhood, and most patients have a chronic disease course requiring prolonged administration of systemic glucocorticoids and immunosuppressive agents. The initial management for patients with moderately severe JDM is relatively standardized, typically including methotrexate and systemic glucocorticoids with…

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug UpdatesMyositisResearch Rheum Tagged with:juvenile dermatomyositisReading Rheum

Young Adults with Psoriatic Disease at Risk of Early Cardiovascular Disease

Anurag Goel, Joshua Tanzer & Vinit Gilvaz  |  November 7, 2024

Background/Purpose Psoriasis and psoriatic arthritis (PsA) are closely linked inflammatory conditions that can affect both children and adults. In children, these diseases are associated with traditional cardiovascular disease risk factors and subclinical atherosclerosis. In older adults, systemic inflammation from psoriasis and PsA accelerates atherosclerosis, and these conditions are independent risk factors for severe cardiovascular disease…

Filed under:ACR ConvergenceConditionsMeeting ReportsPsoriatic Arthritis Tagged with:ACR Convergence 2024ACR Convergence 2024 PsAArthritis & Rheumatology

After Coalition Meeting, CMS Leadership Agrees to Closer Look at Underwater Biosimilars

From the College  |  October 21, 2024

The Underwater Biosimilars Coalition shared with the Centers for Medicare & Medicaid Services concerns about problems arising from the average sales price payment methodology and discussed potential options for addressing these challenges.

Filed under:Billing/CodingLegislation & AdvocacyPractice Support Tagged with:ACR advocacyBiosimilarsCoalition of State Rheumatology Organizations (CSRO)

  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 93
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences